More than one in 10 men is diagnosed with prostate cancer in their lifetimes, a staggering prevalence rate including roughly 200,000 men per year in the US and 50,000 in the UK.1 There have been widespread calls for increased screening for prostate cancer, as early detection and treatment are linked to better survival rates. However, conventional medical treatments are invasive and come with many risks.